Pharmaceutical Commerce
CONTINUE TO SITE >

OR WAIT 15 SECS

Pfizer to supply US with 100 million more doses of vaccine

December 24, 2020

Order raises total number of Covid-19 doses for US to 200 million

Pfizer and development partner BioNTech SE announced a second agreement with the US government to supply an additional 100 million doses of the companies’ Covid-19 vaccine from production facilities in North America. This agreement brings the total number of doses to be delivered to the US to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021. Consistent with the original agreement announced in July, the US government will pay $1.95 billion for the additional 100 million doses.

Under the terms of the second agreement, Pfizer and Germany-based BioNTech will deliver at least 70 million of the additional doses by June 30, 2021, with the remaining 30 million doses to be delivered no later than July 31. The US also has the option to acquire up to an additional 400 million doses.

According to the companies' joint release, eligible US residents will continue to receive the vaccine for free, consistent with the government’s commitment to providing free access for Covid vaccines and according to CDC Advisory Committee on Immunization Practices (ACIP) recommendations for the vaccine’s phased rollout. 

The Pfizer-BioNTech vaccine has not been approved or licensed by the FDA, but has been authorized for emergency use by the agency for individuals 16 years of age and older.